Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties
Abstract Background Zyflamend, a blend of herbal extracts, effectively inhibits tumor growth using preclinical models of castrate-resistant prostate cancer mediated in part by 5′-adenosine monophosphate-activated protein kinase (AMPK), a master energy sensor of the cell. Clinically, treatment with Z...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2018-06-01
|
| Collection: | BMC Complementary and Alternative Medicine |
| Sujets: | |
| Accès en ligne: | http://link.springer.com/article/10.1186/s12906-018-2255-0 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|